Optimizing Antiplatelet Therapy in High-Risk Patients With Atrial Fibrillation: Insights From Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)
Stroke - United States
doi 10.1161/strokeaha.109.568576
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2009
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)